Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Inozyme Pharma, Inc. has filed 378 SEC EDGAR filings since 05 Jan 2017

SEC filing history

Showing 26-50 of 378 matching filings.

Per page
25
Current page
2
SC TO-T/A File 005-91586

SC TO-T/A

Filing date
01 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39397

DEFA14A

Filing date
23 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-91586

SC TO-T/A

Filing date
17 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-91586

SC 14D9/A

Filing date
17 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-91586

SC TO-T/A

Filing date
13 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 005-91586

UPLOAD filing

Filing date
09 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91586

SCHEDULE 13G filing

Filing date
04 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-91586

SC 14D9/A

Filing date
04 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-91586

SC TO-T/A

Filing date
04 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-91586

SC 14D9

Filing date
02 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91586

SCHEDULE 13G/A filing

Filing date
30 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91586

SCHEDULE 13G filing

Filing date
23 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-91586

SC14D9C

Filing date
20 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-91586

SC TO-C

Filing date
19 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-91586

SC TO-C

Filing date
19 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-91586

SC TO-C

Filing date
16 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-91586

SC14D9C

Filing date
16 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .